TrialJournal of gastroenterology2014

Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies.

Namiki Izumi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.